Clinical Trials
3 trialsNCT06585488 2026-06-03
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
BeOne Medicines
Phase 1 Terminated
NCT07087197 2026-05-08
A Study of SKB107 in Advanced Solid Tumors With Bone Metastases
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT04457778 2026-05-04
First in Human Study of M6223
EMD Serono
Phase 1 Completed